| 3.1 |
9.3 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 2.9 |
8.8 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 2.0 |
5.9 |
GO:0030421 |
defecation(GO:0030421) |
| 1.6 |
4.8 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 1.6 |
7.9 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 1.6 |
6.2 |
GO:0072235 |
distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
| 1.5 |
3.1 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.5 |
4.4 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 1.4 |
4.2 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 1.4 |
2.7 |
GO:0032499 |
detection of peptidoglycan(GO:0032499) |
| 1.4 |
1.4 |
GO:0001907 |
killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
| 1.4 |
4.1 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 1.4 |
8.2 |
GO:0071499 |
response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 1.4 |
4.1 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
| 1.2 |
3.7 |
GO:0072223 |
metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 1.2 |
6.1 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 1.2 |
3.6 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 1.2 |
4.8 |
GO:1900426 |
positive regulation of defense response to bacterium(GO:1900426) |
| 1.2 |
2.4 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 1.1 |
3.4 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 1.1 |
2.3 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 1.1 |
2.3 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 1.1 |
1.1 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 1.1 |
4.5 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 1.1 |
3.3 |
GO:0001803 |
type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 1.1 |
3.2 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 1.1 |
4.3 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 1.0 |
5.2 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 1.0 |
1.0 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.0 |
2.1 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 1.0 |
1.0 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 1.0 |
4.0 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 1.0 |
1.0 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 1.0 |
3.9 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 1.0 |
1.0 |
GO:1901145 |
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
| 1.0 |
1.0 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 1.0 |
3.9 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 1.0 |
2.9 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.9 |
6.6 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.9 |
4.7 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.9 |
2.8 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.9 |
1.8 |
GO:2000977 |
regulation of forebrain neuron differentiation(GO:2000977) |
| 0.9 |
1.8 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.9 |
1.8 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.9 |
8.0 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.9 |
2.7 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.9 |
3.6 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.9 |
2.7 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.9 |
2.7 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.9 |
2.7 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.9 |
2.6 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 0.9 |
2.6 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.9 |
6.0 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.9 |
2.6 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.9 |
0.9 |
GO:0060032 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.9 |
2.6 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.8 |
0.8 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.8 |
1.7 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.8 |
0.8 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.8 |
2.5 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.8 |
2.5 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.8 |
3.2 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.8 |
3.2 |
GO:0048819 |
regulation of hair follicle maturation(GO:0048819) regulation of catagen(GO:0051794) |
| 0.8 |
2.4 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.8 |
4.0 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.8 |
5.5 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.8 |
0.8 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.8 |
1.6 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 0.8 |
6.2 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.8 |
0.8 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.8 |
0.8 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.8 |
4.5 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.8 |
2.3 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.7 |
1.5 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.7 |
9.7 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.7 |
1.5 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.7 |
3.7 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.7 |
0.7 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.7 |
5.2 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.7 |
5.1 |
GO:0051940 |
regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 0.7 |
4.4 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 0.7 |
3.6 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.7 |
5.8 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.7 |
2.2 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.7 |
2.9 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.7 |
2.9 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.7 |
4.3 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.7 |
5.7 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.7 |
2.8 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.7 |
4.3 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.7 |
1.4 |
GO:0035793 |
cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.7 |
2.1 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.7 |
5.5 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.7 |
2.7 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.7 |
1.3 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) regulation of neuroblast proliferation(GO:1902692) |
| 0.7 |
1.3 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.7 |
1.3 |
GO:0072197 |
ureter morphogenesis(GO:0072197) metanephric nephron tubule formation(GO:0072289) |
| 0.7 |
4.0 |
GO:1903275 |
positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.7 |
2.6 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.7 |
1.3 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.7 |
0.7 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.7 |
2.6 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.7 |
2.0 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.7 |
1.3 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.7 |
0.7 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.6 |
1.9 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.6 |
0.6 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.6 |
2.6 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.6 |
5.1 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.6 |
0.6 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.6 |
12.7 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.6 |
3.8 |
GO:0003180 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
| 0.6 |
3.7 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.6 |
1.2 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.6 |
1.2 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.6 |
0.6 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.6 |
1.2 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.6 |
1.8 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.6 |
2.4 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.6 |
1.8 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.6 |
1.8 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.6 |
3.0 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.6 |
1.2 |
GO:0060231 |
mesenchymal to epithelial transition(GO:0060231) |
| 0.6 |
4.1 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.6 |
0.6 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.6 |
2.9 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.6 |
2.3 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.6 |
0.6 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.6 |
1.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.6 |
2.3 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.6 |
0.6 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.6 |
2.3 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.6 |
3.5 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.6 |
10.9 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.6 |
0.6 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.6 |
2.9 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.6 |
2.8 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.6 |
1.7 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.6 |
1.7 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.6 |
1.7 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.6 |
2.8 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.6 |
1.7 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.6 |
5.5 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.6 |
0.6 |
GO:0045915 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.5 |
2.2 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
| 0.5 |
0.5 |
GO:0072038 |
mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
| 0.5 |
1.6 |
GO:0046645 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.5 |
0.5 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.5 |
2.2 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.5 |
1.6 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.5 |
1.6 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.5 |
1.1 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.5 |
2.7 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.5 |
4.3 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.5 |
0.5 |
GO:0061074 |
regulation of neural retina development(GO:0061074) |
| 0.5 |
1.6 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.5 |
1.1 |
GO:2000851 |
positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.5 |
1.1 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.5 |
0.5 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.5 |
1.6 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.5 |
2.1 |
GO:0032610 |
interleukin-1 alpha production(GO:0032610) |
| 0.5 |
1.1 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 0.5 |
0.5 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.5 |
1.6 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.5 |
1.6 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.5 |
1.6 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.5 |
1.6 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.5 |
0.5 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.5 |
1.0 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.5 |
0.5 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.5 |
1.5 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.5 |
2.1 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.5 |
1.5 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.5 |
0.5 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.5 |
1.5 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.5 |
3.1 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.5 |
2.0 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.5 |
1.5 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.5 |
1.0 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.5 |
3.1 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.5 |
1.5 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.5 |
2.0 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.5 |
2.5 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.5 |
2.5 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.5 |
1.5 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.5 |
1.0 |
GO:2001212 |
regulation of vasculogenesis(GO:2001212) |
| 0.5 |
0.5 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.5 |
0.5 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.5 |
3.4 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.5 |
0.5 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.5 |
0.5 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.5 |
1.9 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.5 |
0.5 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.5 |
1.5 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.5 |
1.4 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.5 |
1.4 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.5 |
1.9 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.5 |
1.4 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.5 |
2.4 |
GO:0000050 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.5 |
1.4 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.5 |
4.7 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.5 |
1.9 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.5 |
3.2 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.5 |
1.8 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.5 |
3.2 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.5 |
5.1 |
GO:1902306 |
negative regulation of sodium ion transmembrane transport(GO:1902306) |
| 0.5 |
1.4 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.5 |
1.4 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.5 |
0.5 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 0.5 |
1.4 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.5 |
0.9 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.5 |
0.9 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.5 |
0.5 |
GO:0090191 |
negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.5 |
0.9 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.5 |
1.4 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.5 |
3.6 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.5 |
0.9 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.4 |
5.4 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.4 |
2.7 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.4 |
1.8 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.4 |
2.2 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.4 |
0.9 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.4 |
1.3 |
GO:0010935 |
regulation of macrophage cytokine production(GO:0010935) |
| 0.4 |
2.7 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.4 |
0.9 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.4 |
1.3 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.4 |
0.9 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.4 |
3.5 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.4 |
0.9 |
GO:0048143 |
astrocyte activation(GO:0048143) |
| 0.4 |
0.9 |
GO:2001267 |
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.4 |
0.4 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.4 |
3.0 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.4 |
1.3 |
GO:0060978 |
angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.4 |
0.4 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.4 |
0.4 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.4 |
0.4 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.4 |
0.4 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.4 |
2.1 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.4 |
1.3 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.4 |
1.3 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.4 |
2.1 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.4 |
1.3 |
GO:1901628 |
positive regulation of postsynaptic membrane organization(GO:1901628) |
| 0.4 |
1.7 |
GO:0009227 |
nucleotide-sugar catabolic process(GO:0009227) |
| 0.4 |
0.4 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.4 |
0.8 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.4 |
5.4 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.4 |
0.8 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.4 |
0.4 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.4 |
0.8 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.4 |
2.5 |
GO:1902847 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.4 |
1.2 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.4 |
1.6 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.4 |
0.4 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.4 |
1.2 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.4 |
1.6 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.4 |
2.4 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.4 |
2.0 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.4 |
1.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.4 |
2.0 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.4 |
1.2 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.4 |
0.4 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.4 |
0.4 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.4 |
1.6 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.4 |
0.8 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.4 |
2.4 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.4 |
1.2 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.4 |
2.8 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.4 |
2.4 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.4 |
1.6 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.4 |
1.2 |
GO:0090259 |
regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.4 |
1.2 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.4 |
0.4 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 0.4 |
2.0 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.4 |
5.5 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.4 |
1.6 |
GO:1904426 |
positive regulation of GTP binding(GO:1904426) |
| 0.4 |
2.7 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.4 |
5.4 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.4 |
0.4 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
| 0.4 |
1.2 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.4 |
0.4 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.4 |
0.8 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.4 |
2.7 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.4 |
1.1 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.4 |
1.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.4 |
0.4 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.4 |
0.4 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.4 |
5.7 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.4 |
1.1 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.4 |
1.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.4 |
4.2 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.4 |
3.4 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.4 |
1.1 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.4 |
4.5 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) |
| 0.4 |
3.4 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.4 |
2.6 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.4 |
3.7 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.4 |
2.6 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.4 |
2.6 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.4 |
1.5 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.4 |
2.6 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.4 |
0.7 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.4 |
1.1 |
GO:0009169 |
purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.4 |
0.7 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 |
3.6 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.4 |
0.7 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.4 |
2.9 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.4 |
1.4 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.4 |
1.1 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.4 |
1.1 |
GO:0048865 |
stem cell fate commitment(GO:0048865) stem cell fate specification(GO:0048866) |
| 0.4 |
1.4 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.4 |
0.4 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) regulation of apoptotic process involved in morphogenesis(GO:1902337) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) regulation of apoptotic process involved in development(GO:1904748) |
| 0.4 |
2.2 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.4 |
0.7 |
GO:0035137 |
hindlimb morphogenesis(GO:0035137) |
| 0.4 |
1.8 |
GO:0086013 |
membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
| 0.4 |
1.4 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.4 |
5.0 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.4 |
0.4 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.4 |
0.7 |
GO:0000255 |
allantoin metabolic process(GO:0000255) creatine metabolic process(GO:0006600) |
| 0.4 |
1.8 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.4 |
2.5 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.4 |
2.5 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.4 |
0.7 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.4 |
0.4 |
GO:0001774 |
microglial cell activation(GO:0001774) |
| 0.4 |
2.1 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.4 |
2.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.4 |
1.4 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.4 |
1.4 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.4 |
0.4 |
GO:0097154 |
GABAergic neuron differentiation(GO:0097154) |
| 0.3 |
0.3 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.3 |
0.7 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.3 |
0.7 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.3 |
1.0 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.3 |
2.4 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.3 |
3.8 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.3 |
1.4 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.3 |
2.4 |
GO:0050951 |
sensory perception of temperature stimulus(GO:0050951) |
| 0.3 |
0.7 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.3 |
1.4 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.3 |
5.4 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.3 |
1.0 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.3 |
0.3 |
GO:0043489 |
RNA stabilization(GO:0043489) |
| 0.3 |
2.4 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.3 |
1.0 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 |
1.7 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 |
1.3 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.3 |
0.3 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.3 |
1.7 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.3 |
11.3 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.3 |
1.3 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.3 |
2.0 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.3 |
0.7 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.3 |
1.0 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.3 |
2.6 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.3 |
0.3 |
GO:0045909 |
positive regulation of vasodilation(GO:0045909) |
| 0.3 |
3.6 |
GO:0051126 |
negative regulation of actin nucleation(GO:0051126) |
| 0.3 |
1.3 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.3 |
1.9 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.3 |
1.6 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 0.3 |
1.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 |
1.6 |
GO:0003253 |
cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
| 0.3 |
0.6 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.3 |
1.0 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.3 |
0.6 |
GO:1902308 |
regulation of peptidyl-serine dephosphorylation(GO:1902308) |
| 0.3 |
2.2 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.3 |
1.0 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.3 |
1.6 |
GO:0060872 |
semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
| 0.3 |
2.5 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.3 |
0.3 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.3 |
2.2 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.3 |
1.0 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 |
0.9 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.3 |
1.6 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.3 |
1.9 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.3 |
0.9 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.3 |
1.9 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.3 |
1.2 |
GO:0071726 |
response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.3 |
4.4 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.3 |
0.3 |
GO:2000468 |
regulation of peroxidase activity(GO:2000468) |
| 0.3 |
0.9 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.3 |
0.3 |
GO:0060375 |
regulation of mast cell differentiation(GO:0060375) |
| 0.3 |
1.9 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.3 |
1.2 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.3 |
0.6 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.3 |
3.1 |
GO:0046051 |
UTP metabolic process(GO:0046051) |
| 0.3 |
0.3 |
GO:2000378 |
negative regulation of reactive oxygen species metabolic process(GO:2000378) |
| 0.3 |
2.8 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.3 |
1.8 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.3 |
1.5 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
| 0.3 |
1.5 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.3 |
0.6 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.3 |
0.3 |
GO:0036482 |
neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.3 |
2.1 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.3 |
0.6 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.3 |
0.9 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.3 |
0.6 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 |
0.3 |
GO:0006598 |
polyamine catabolic process(GO:0006598) |
| 0.3 |
1.2 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.3 |
2.1 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.3 |
0.3 |
GO:0019755 |
one-carbon compound transport(GO:0019755) |
| 0.3 |
0.3 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.3 |
1.2 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.3 |
1.2 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.3 |
1.8 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.3 |
1.5 |
GO:0045144 |
meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
| 0.3 |
1.2 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.3 |
0.9 |
GO:0002283 |
neutrophil activation involved in immune response(GO:0002283) |
| 0.3 |
0.3 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.3 |
1.5 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.3 |
2.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.3 |
0.3 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.3 |
1.8 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.3 |
0.9 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.3 |
0.3 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.3 |
4.1 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.3 |
1.2 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.3 |
1.2 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.3 |
0.3 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.3 |
1.1 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.3 |
1.4 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.3 |
0.3 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.3 |
0.3 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.3 |
7.1 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.3 |
0.6 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.3 |
1.1 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.3 |
0.9 |
GO:0043465 |
regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
| 0.3 |
0.3 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.3 |
0.3 |
GO:0032692 |
negative regulation of interleukin-1 production(GO:0032692) |
| 0.3 |
0.3 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.3 |
4.0 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.3 |
0.8 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.3 |
3.7 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.3 |
2.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 |
0.8 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.3 |
0.8 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.3 |
0.3 |
GO:0072210 |
metanephric nephron development(GO:0072210) |
| 0.3 |
0.3 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) olefin metabolic process(GO:1900673) |
| 0.3 |
1.1 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.3 |
1.4 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.3 |
0.8 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.3 |
0.8 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.3 |
0.3 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.3 |
0.8 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 |
0.5 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.3 |
1.1 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.3 |
0.3 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.3 |
2.7 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.3 |
2.7 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.3 |
0.3 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 |
1.1 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.3 |
0.8 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.3 |
0.3 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.3 |
0.5 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.3 |
0.3 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.3 |
0.3 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.3 |
0.8 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.3 |
1.6 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.3 |
2.1 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.3 |
0.8 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.3 |
1.1 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.3 |
0.3 |
GO:0050857 |
positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
| 0.3 |
3.5 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.3 |
4.0 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.3 |
1.9 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 |
0.3 |
GO:0010872 |
regulation of cholesterol esterification(GO:0010872) |
| 0.3 |
4.0 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.3 |
2.1 |
GO:0042435 |
indole-containing compound biosynthetic process(GO:0042435) |
| 0.3 |
0.8 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.3 |
0.8 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.3 |
0.5 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.3 |
0.5 |
GO:0021984 |
adenohypophysis development(GO:0021984) |
| 0.3 |
0.3 |
GO:0071320 |
cellular response to cAMP(GO:0071320) |
| 0.3 |
4.7 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.3 |
1.8 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.3 |
4.4 |
GO:0071353 |
response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
| 0.3 |
1.3 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.3 |
1.0 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.3 |
0.3 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.3 |
0.5 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.3 |
0.3 |
GO:2000173 |
negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.3 |
2.6 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.3 |
2.6 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.3 |
1.3 |
GO:1902430 |
negative regulation of beta-amyloid formation(GO:1902430) |
| 0.3 |
1.0 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.3 |
0.5 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.3 |
0.3 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.3 |
1.3 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.3 |
0.3 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.3 |
0.3 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.3 |
2.8 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.3 |
0.3 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.3 |
0.5 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.3 |
0.3 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.3 |
2.3 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.3 |
0.8 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.3 |
0.5 |
GO:2000338 |
response to molecule of fungal origin(GO:0002238) chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
| 0.3 |
0.8 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.3 |
3.3 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.3 |
0.8 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.3 |
3.5 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.3 |
0.3 |
GO:0032042 |
mitochondrial DNA metabolic process(GO:0032042) |
| 0.3 |
0.8 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.3 |
0.8 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 |
3.0 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.2 |
2.0 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.2 |
0.2 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.2 |
1.7 |
GO:0090049 |
regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
| 0.2 |
1.5 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.2 |
1.0 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.2 |
1.5 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.2 |
3.2 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.2 |
2.5 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 |
0.5 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.2 |
0.7 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.2 |
0.5 |
GO:0021892 |
cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
| 0.2 |
0.5 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.2 |
1.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.2 |
1.0 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.2 |
0.2 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
| 0.2 |
0.2 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.2 |
0.2 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) |
| 0.2 |
0.5 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.2 |
0.7 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 |
1.7 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.2 |
0.5 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.2 |
3.4 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.2 |
0.2 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.2 |
0.2 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.2 |
1.0 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 |
0.7 |
GO:0033080 |
immature T cell proliferation in thymus(GO:0033080) |
| 0.2 |
1.0 |
GO:0051883 |
disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
| 0.2 |
2.2 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.2 |
0.7 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.2 |
0.5 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.2 |
0.7 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
| 0.2 |
0.2 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.2 |
0.2 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 |
0.5 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.2 |
0.7 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.2 |
0.2 |
GO:0010586 |
miRNA metabolic process(GO:0010586) |
| 0.2 |
0.2 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.2 |
3.7 |
GO:0071466 |
cellular response to xenobiotic stimulus(GO:0071466) |
| 0.2 |
0.2 |
GO:1904152 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 |
0.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 |
7.4 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.2 |
5.3 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.2 |
1.2 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 |
0.2 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.2 |
0.2 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 0.2 |
0.7 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 |
3.4 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.2 |
0.2 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.2 |
2.0 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.2 |
0.9 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 |
0.2 |
GO:0042228 |
interleukin-8 biosynthetic process(GO:0042228) |
| 0.2 |
0.7 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 |
0.7 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.2 |
0.2 |
GO:0070171 |
negative regulation of tooth mineralization(GO:0070171) |
| 0.2 |
1.6 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
| 0.2 |
1.1 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 0.2 |
0.7 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 |
0.4 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.2 |
0.7 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.2 |
0.7 |
GO:0045649 |
regulation of macrophage differentiation(GO:0045649) |
| 0.2 |
0.4 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.2 |
0.2 |
GO:0071035 |
polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.2 |
0.2 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 |
0.7 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 |
0.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 |
2.2 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.2 |
7.8 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.2 |
1.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.2 |
0.9 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 |
0.4 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.2 |
0.6 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.2 |
0.4 |
GO:0021936 |
regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.2 |
0.9 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.2 |
0.2 |
GO:0010455 |
positive regulation of cell fate commitment(GO:0010455) |
| 0.2 |
1.5 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.2 |
0.2 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.2 |
0.2 |
GO:0032714 |
negative regulation of interleukin-13 production(GO:0032696) negative regulation of interleukin-5 production(GO:0032714) oligodendrocyte apoptotic process(GO:0097252) |
| 0.2 |
0.9 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.2 |
2.8 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.2 |
1.7 |
GO:0045987 |
positive regulation of smooth muscle contraction(GO:0045987) |
| 0.2 |
0.4 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.2 |
0.8 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.2 |
0.4 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.2 |
0.6 |
GO:1905050 |
positive regulation of metalloendopeptidase activity(GO:1904685) positive regulation of metallopeptidase activity(GO:1905050) |
| 0.2 |
0.6 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.2 |
1.1 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.2 |
1.1 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.2 |
0.4 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.2 |
0.2 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.2 |
0.4 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.2 |
1.7 |
GO:0021534 |
cell proliferation in hindbrain(GO:0021534) |
| 0.2 |
0.4 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.2 |
1.0 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.2 |
0.2 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.2 |
0.6 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.2 |
0.8 |
GO:1902047 |
polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.2 |
0.8 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 |
1.5 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.2 |
0.2 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.2 |
0.8 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.2 |
0.8 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.2 |
0.8 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.2 |
0.8 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.2 |
0.4 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.2 |
0.6 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.2 |
0.2 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 |
8.2 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.2 |
0.6 |
GO:2000569 |
T-helper 2 cell activation(GO:0035712) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.2 |
0.6 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.2 |
0.4 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.2 |
0.6 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.2 |
0.6 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.2 |
1.6 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
1.8 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.2 |
0.2 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.2 |
0.8 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.2 |
0.2 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.2 |
1.2 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.2 |
2.8 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.2 |
0.4 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.2 |
0.8 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 |
0.6 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.2 |
0.4 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.2 |
0.2 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.2 |
0.2 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.2 |
0.6 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.2 |
0.4 |
GO:0035928 |
RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
| 0.2 |
0.6 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.2 |
0.8 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.2 |
1.0 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.2 |
0.6 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.2 |
0.8 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.2 |
0.8 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.2 |
0.2 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 0.2 |
1.2 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.2 |
0.6 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
0.2 |
GO:0000288 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.2 |
2.0 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.2 |
2.7 |
GO:0048806 |
genitalia development(GO:0048806) |
| 0.2 |
0.8 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.2 |
0.8 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.2 |
0.4 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.2 |
4.1 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.2 |
0.6 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 |
0.4 |
GO:0003356 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.2 |
0.4 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.2 |
0.2 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.2 |
0.4 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.2 |
0.6 |
GO:0060850 |
regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.2 |
1.0 |
GO:0045624 |
positive regulation of T-helper cell differentiation(GO:0045624) |
| 0.2 |
12.9 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.2 |
0.2 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.2 |
0.2 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.2 |
6.2 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.2 |
0.6 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.2 |
4.0 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.2 |
0.6 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
0.8 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 0.2 |
0.6 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 |
0.2 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.2 |
1.5 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.2 |
3.4 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.2 |
0.6 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 |
0.2 |
GO:0003198 |
epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
| 0.2 |
0.4 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.2 |
0.2 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.2 |
0.4 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.2 |
0.9 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.2 |
0.4 |
GO:2000679 |
positive regulation of transcription regulatory region DNA binding(GO:2000679) |
| 0.2 |
0.6 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.2 |
0.4 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.2 |
1.7 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.2 |
1.8 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.2 |
2.2 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
0.2 |
GO:0032466 |
negative regulation of cytokinesis(GO:0032466) |
| 0.2 |
0.4 |
GO:2000152 |
regulation of ubiquitin-specific protease activity(GO:2000152) |
| 0.2 |
1.1 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.2 |
0.5 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.2 |
0.2 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.2 |
0.4 |
GO:0007418 |
ventral midline development(GO:0007418) |
| 0.2 |
1.1 |
GO:0035813 |
renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
| 0.2 |
0.4 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.2 |
1.3 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.2 |
4.3 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 |
1.4 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.2 |
0.9 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 |
0.2 |
GO:0019405 |
hexitol metabolic process(GO:0006059) alditol catabolic process(GO:0019405) |
| 0.2 |
0.4 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.2 |
1.1 |
GO:0046502 |
uroporphyrinogen III metabolic process(GO:0046502) |
| 0.2 |
7.2 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.2 |
0.2 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.2 |
0.9 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 |
0.4 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.2 |
0.2 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.2 |
1.9 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 |
1.9 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.2 |
0.5 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.2 |
0.7 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.2 |
0.9 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) initiation of neural tube closure(GO:0021993) |
| 0.2 |
0.7 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.2 |
0.2 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.2 |
0.7 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.2 |
2.1 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.2 |
0.3 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.2 |
0.3 |
GO:0019048 |
modulation by virus of host morphology or physiology(GO:0019048) |
| 0.2 |
6.0 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.2 |
0.2 |
GO:0014062 |
regulation of serotonin secretion(GO:0014062) |
| 0.2 |
0.5 |
GO:1901881 |
positive regulation of protein depolymerization(GO:1901881) |
| 0.2 |
4.8 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.2 |
0.8 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.2 |
0.2 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.2 |
0.5 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
0.3 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.2 |
1.3 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.2 |
1.2 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.2 |
2.0 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
0.8 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
0.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.2 |
0.5 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.2 |
1.2 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 |
0.7 |
GO:0019249 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
| 0.2 |
0.7 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.2 |
0.8 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 |
0.2 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.2 |
0.3 |
GO:0051303 |
establishment of chromosome localization(GO:0051303) |
| 0.2 |
0.2 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.2 |
0.5 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
0.7 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.2 |
1.3 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.2 |
0.6 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.2 |
1.1 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.2 |
0.8 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.2 |
2.6 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.2 |
0.2 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.2 |
0.8 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.2 |
1.8 |
GO:0070193 |
synaptonemal complex organization(GO:0070193) |
| 0.2 |
0.2 |
GO:0072367 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.2 |
0.2 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.2 |
0.5 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 |
0.5 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.2 |
0.5 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 0.2 |
0.3 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.2 |
1.1 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.2 |
0.6 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 |
0.2 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.2 |
0.2 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.2 |
0.6 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 |
0.2 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.2 |
2.3 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 |
0.8 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.2 |
0.6 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.2 |
1.7 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.2 |
0.6 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.2 |
0.3 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.2 |
0.5 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 |
0.2 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.2 |
0.2 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.2 |
0.8 |
GO:1901341 |
positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 |
0.2 |
GO:0042506 |
tyrosine phosphorylation of Stat5 protein(GO:0042506) |
| 0.2 |
0.5 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.2 |
0.5 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.2 |
0.6 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.2 |
0.5 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.2 |
0.3 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 |
1.4 |
GO:0042775 |
mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.2 |
2.6 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.1 |
0.7 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
1.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.4 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.4 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 |
0.1 |
GO:0043516 |
regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
| 0.1 |
0.3 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
1.3 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.1 |
0.6 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
0.1 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 |
0.4 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 |
0.1 |
GO:0070827 |
chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.3 |
GO:0010454 |
negative regulation of cell fate commitment(GO:0010454) |
| 0.1 |
1.3 |
GO:0071451 |
cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.1 |
0.6 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.1 |
0.3 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
1.6 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.4 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 |
0.6 |
GO:0060444 |
branching involved in mammary gland duct morphogenesis(GO:0060444) |
| 0.1 |
0.4 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
1.4 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
0.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.1 |
0.3 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.1 |
1.0 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.3 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 |
0.8 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
1.1 |
GO:0015868 |
purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.1 |
0.3 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.3 |
GO:0032376 |
positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
| 0.1 |
0.7 |
GO:0046135 |
pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 |
0.3 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.1 |
0.7 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
0.4 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.1 |
0.6 |
GO:1904417 |
regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.1 |
0.7 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.1 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.1 |
0.3 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.1 |
1.0 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 |
0.7 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.8 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 |
0.3 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 |
3.0 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
1.4 |
GO:0002526 |
acute inflammatory response(GO:0002526) |
| 0.1 |
0.1 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.1 |
0.1 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.1 |
0.4 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.1 |
1.8 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.5 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 |
0.8 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
0.7 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 |
0.4 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.4 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 |
0.3 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 |
0.7 |
GO:0042401 |
amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
| 0.1 |
0.1 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) progesterone metabolic process(GO:0042448) |
| 0.1 |
0.1 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
0.3 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.1 |
1.1 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
1.2 |
GO:0046033 |
AMP metabolic process(GO:0046033) |
| 0.1 |
0.1 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.1 |
0.9 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 |
0.5 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) |
| 0.1 |
0.9 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.1 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.1 |
1.2 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
0.4 |
GO:0043181 |
diaphragm contraction(GO:0002086) vacuolar sequestering(GO:0043181) |
| 0.1 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.1 |
0.8 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.1 |
0.7 |
GO:0022615 |
protein import into peroxisome matrix, docking(GO:0016560) protein to membrane docking(GO:0022615) |
| 0.1 |
1.7 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.5 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.1 |
0.3 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 |
0.3 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
1.9 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
0.3 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.1 |
0.3 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 |
1.5 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.1 |
0.1 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.1 |
2.1 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.1 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.1 |
3.1 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
0.3 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 |
0.3 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.1 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.1 |
1.6 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.1 |
2.0 |
GO:0008593 |
regulation of Notch signaling pathway(GO:0008593) |
| 0.1 |
0.4 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.1 |
0.4 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.1 |
0.1 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.3 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
0.8 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.4 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.1 |
1.7 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 |
0.5 |
GO:0051591 |
response to cAMP(GO:0051591) |
| 0.1 |
0.1 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.1 |
0.6 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.1 |
0.5 |
GO:0033628 |
regulation of cell adhesion mediated by integrin(GO:0033628) |
| 0.1 |
0.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
0.6 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
0.1 |
GO:0033604 |
negative regulation of catecholamine secretion(GO:0033604) |
| 0.1 |
0.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.7 |
GO:0008050 |
courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
| 0.1 |
0.9 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 |
0.2 |
GO:0072337 |
modified amino acid transport(GO:0072337) |
| 0.1 |
0.2 |
GO:1903867 |
chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
| 0.1 |
0.6 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.7 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.1 |
0.1 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 |
0.2 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
0.8 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.1 |
0.2 |
GO:2000343 |
positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.1 |
0.5 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.1 |
0.2 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
0.4 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.5 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.2 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.1 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 |
0.2 |
GO:1990748 |
cellular detoxification(GO:1990748) |
| 0.1 |
0.7 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
5.6 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
2.7 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.1 |
1.4 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.1 |
0.1 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 |
0.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.2 |
GO:0006691 |
leukotriene metabolic process(GO:0006691) |
| 0.1 |
0.6 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 |
0.5 |
GO:0010755 |
regulation of plasminogen activation(GO:0010755) |
| 0.1 |
0.8 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.1 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.1 |
0.2 |
GO:0090559 |
regulation of membrane permeability(GO:0090559) |
| 0.1 |
0.2 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 |
0.9 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.1 |
0.3 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 |
0.1 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 |
0.2 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
0.5 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.1 |
0.3 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
1.4 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
0.7 |
GO:1901032 |
negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.1 |
0.1 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.1 |
0.5 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.1 |
0.6 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.6 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.7 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.1 |
0.6 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.1 |
0.1 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.1 |
1.1 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.2 |
GO:1901722 |
regulation of cell proliferation involved in kidney development(GO:1901722) |
| 0.1 |
2.6 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.1 |
1.0 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.1 |
0.4 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
1.1 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.1 |
0.3 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.1 |
0.8 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 |
0.3 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.1 |
0.6 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.2 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.1 |
0.2 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.3 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.1 |
0.5 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.1 |
1.7 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.2 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.1 |
0.2 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
0.2 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 |
0.5 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
0.2 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.1 |
0.6 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
1.2 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.1 |
0.6 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.1 |
0.5 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 |
0.5 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
0.2 |
GO:0042523 |
positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
| 0.1 |
1.1 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
0.2 |
GO:1902624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
| 0.1 |
0.1 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 |
0.4 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 |
0.3 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.1 |
1.0 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
0.4 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
0.2 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.1 |
0.8 |
GO:0042987 |
amyloid precursor protein catabolic process(GO:0042987) |
| 0.1 |
0.3 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.2 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.3 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.1 |
0.6 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
0.3 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
0.1 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 |
0.4 |
GO:1903670 |
regulation of sprouting angiogenesis(GO:1903670) |
| 0.1 |
1.1 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.5 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
| 0.1 |
0.3 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.1 |
0.2 |
GO:0019068 |
virion assembly(GO:0019068) |
| 0.1 |
0.1 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.1 |
0.4 |
GO:0071675 |
regulation of mononuclear cell migration(GO:0071675) |
| 0.1 |
0.2 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
0.1 |
GO:0072079 |
ureteric bud formation(GO:0060676) nephron tubule formation(GO:0072079) |
| 0.1 |
0.5 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 |
0.2 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.1 |
0.1 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.1 |
0.3 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
0.4 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.1 |
0.3 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 |
0.8 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.1 |
1.7 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.1 |
1.4 |
GO:0006656 |
phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 |
2.4 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.4 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.1 |
0.4 |
GO:0032094 |
response to food(GO:0032094) |
| 0.1 |
0.5 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.1 |
0.2 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.1 |
2.8 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.1 |
GO:2000644 |
regulation of receptor catabolic process(GO:2000644) |
| 0.1 |
1.9 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.3 |
GO:0090155 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 |
0.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.4 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.1 |
0.7 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) |
| 0.1 |
0.1 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.1 |
0.7 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.1 |
0.8 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
0.3 |
GO:0071731 |
response to nitric oxide(GO:0071731) |
| 0.1 |
0.7 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.1 |
0.4 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 |
1.1 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.1 |
3.5 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.3 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.1 |
2.9 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.4 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 0.1 |
0.7 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
0.3 |
GO:0071907 |
determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.1 |
1.4 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.3 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.2 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 |
0.3 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.1 |
0.3 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.3 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.1 |
0.2 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.1 |
0.3 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.1 |
1.7 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
1.4 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.1 |
0.1 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.1 |
0.8 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
0.2 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.1 |
0.6 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.1 |
0.4 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.1 |
0.2 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.1 |
0.6 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.1 |
0.3 |
GO:0038089 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.1 |
1.3 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
2.0 |
GO:0033692 |
cellular polysaccharide biosynthetic process(GO:0033692) |
| 0.1 |
0.2 |
GO:0002718 |
regulation of cytokine production involved in immune response(GO:0002718) |
| 0.1 |
0.2 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.1 |
0.2 |
GO:0016114 |
terpenoid biosynthetic process(GO:0016114) |
| 0.1 |
1.3 |
GO:0042304 |
regulation of fatty acid biosynthetic process(GO:0042304) |
| 0.1 |
0.2 |
GO:0001821 |
histamine secretion(GO:0001821) |
| 0.1 |
0.1 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 |
0.2 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.1 |
0.4 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
0.6 |
GO:0051125 |
regulation of actin nucleation(GO:0051125) |
| 0.1 |
0.6 |
GO:0016137 |
glycoside metabolic process(GO:0016137) |
| 0.1 |
0.1 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.1 |
0.2 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 |
0.9 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.2 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 |
0.9 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
0.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.2 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.1 |
0.2 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.2 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 |
0.3 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
0.2 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
2.3 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
2.8 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.1 |
0.1 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 |
0.5 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
0.4 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.1 |
0.1 |
GO:0090114 |
COPII-coated vesicle budding(GO:0090114) |
| 0.1 |
0.3 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.1 |
0.1 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.2 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 |
0.1 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.1 |
0.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.7 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 |
0.1 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.1 |
0.9 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.1 |
0.2 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.5 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.6 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.3 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.1 |
0.1 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.1 |
0.3 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.1 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.1 |
0.1 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.6 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.1 |
0.1 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
1.2 |
GO:0009145 |
purine nucleoside triphosphate biosynthetic process(GO:0009145) |
| 0.1 |
0.2 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.1 |
0.1 |
GO:1902861 |
copper ion import into cell(GO:1902861) |
| 0.1 |
0.1 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
0.4 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.3 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.1 |
0.1 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.1 |
0.2 |
GO:0051311 |
meiotic metaphase plate congression(GO:0051311) |
| 0.1 |
0.3 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.1 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.1 |
0.1 |
GO:0061365 |
positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.1 |
0.3 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.1 |
0.9 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.1 |
0.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.1 |
0.2 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 |
0.1 |
GO:2001053 |
regulation of mesenchymal cell apoptotic process(GO:2001053) |
| 0.1 |
0.1 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.1 |
0.3 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.3 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.2 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 |
0.3 |
GO:0006787 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
| 0.1 |
0.1 |
GO:2001021 |
negative regulation of response to DNA damage stimulus(GO:2001021) |
| 0.1 |
0.1 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.1 |
0.1 |
GO:0007620 |
copulation(GO:0007620) |
| 0.1 |
0.3 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.3 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.1 |
0.2 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
2.8 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.1 |
0.2 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
2.1 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.1 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 |
0.2 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.7 |
GO:1903077 |
negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.1 |
0.4 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.1 |
0.8 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.1 |
0.3 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.1 |
0.3 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.1 |
0.4 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.1 |
0.1 |
GO:0097009 |
energy homeostasis(GO:0097009) |
| 0.1 |
0.1 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.1 |
0.1 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.1 |
2.3 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.1 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.1 |
0.2 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.3 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.3 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.1 |
0.2 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
0.3 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 |
0.2 |
GO:0043649 |
dicarboxylic acid catabolic process(GO:0043649) |
| 0.1 |
0.2 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.1 |
0.1 |
GO:0043173 |
nucleotide salvage(GO:0043173) |
| 0.1 |
0.2 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
0.1 |
GO:0042558 |
pteridine-containing compound metabolic process(GO:0042558) |
| 0.1 |
0.2 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.1 |
0.1 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.1 |
0.3 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
0.1 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.1 |
0.2 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.1 |
0.1 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.1 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
| 0.1 |
0.2 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
0.6 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.1 |
0.2 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.3 |
GO:0060193 |
positive regulation of lipase activity(GO:0060193) |
| 0.1 |
0.2 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.1 |
0.4 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.7 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
0.1 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.1 |
0.3 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
1.1 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.6 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.1 |
0.1 |
GO:0060324 |
face development(GO:0060324) |
| 0.1 |
0.9 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.1 |
0.2 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.0 |
0.1 |
GO:0098754 |
detoxification(GO:0098754) |
| 0.0 |
0.0 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.0 |
0.2 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.5 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.0 |
0.0 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.0 |
0.1 |
GO:0014842 |
skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.0 |
0.1 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.1 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.2 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
| 0.0 |
1.1 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.0 |
0.6 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.6 |
GO:0032329 |
serine transport(GO:0032329) |
| 0.0 |
0.6 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.1 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.0 |
1.1 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.8 |
GO:1901184 |
regulation of ERBB signaling pathway(GO:1901184) |
| 0.0 |
1.2 |
GO:1902668 |
negative regulation of axon guidance(GO:1902668) |
| 0.0 |
0.1 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 |
0.5 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 |
0.6 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.1 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.0 |
0.3 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.0 |
0.0 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.0 |
0.2 |
GO:0014741 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
| 0.0 |
0.1 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.0 |
0.0 |
GO:0042345 |
regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.0 |
0.0 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.0 |
0.3 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.0 |
0.1 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 |
0.1 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.0 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.0 |
0.0 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.0 |
0.4 |
GO:0033003 |
regulation of mast cell activation(GO:0033003) |
| 0.0 |
0.0 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.0 |
0.5 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.0 |
0.2 |
GO:0033233 |
regulation of protein sumoylation(GO:0033233) |
| 0.0 |
0.1 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.0 |
0.2 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.0 |
0.1 |
GO:1902176 |
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.0 |
0.0 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.0 |
0.1 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.0 |
0.2 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.1 |
GO:0042510 |
regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
| 0.0 |
0.2 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.0 |
0.4 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.0 |
GO:0072677 |
eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
| 0.0 |
0.3 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
0.0 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.0 |
0.2 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 |
0.3 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.0 |
0.2 |
GO:0001765 |
membrane raft assembly(GO:0001765) |
| 0.0 |
0.3 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.5 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
0.0 |
GO:0002828 |
regulation of type 2 immune response(GO:0002828) |
| 0.0 |
0.2 |
GO:1902229 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
| 0.0 |
0.1 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.0 |
0.1 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.5 |
GO:0023058 |
adaptation of signaling pathway(GO:0023058) |
| 0.0 |
0.2 |
GO:0051958 |
methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.0 |
0.1 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.0 |
0.0 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.2 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.0 |
0.3 |
GO:0006833 |
water transport(GO:0006833) |
| 0.0 |
0.1 |
GO:0060690 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) |
| 0.0 |
0.1 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.0 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.0 |
0.2 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.3 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.0 |
0.0 |
GO:0045763 |
negative regulation of cellular amine metabolic process(GO:0033239) negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.0 |
0.8 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.1 |
GO:0032367 |
intracellular cholesterol transport(GO:0032367) |
| 0.0 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.1 |
GO:0044794 |
positive regulation by host of viral process(GO:0044794) |
| 0.0 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 |
0.0 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 |
0.0 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.1 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.0 |
0.1 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.0 |
0.2 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.1 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.0 |
0.0 |
GO:0044110 |
growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
| 0.0 |
0.0 |
GO:0032727 |
positive regulation of interferon-alpha production(GO:0032727) |
| 0.0 |
0.1 |
GO:0021781 |
glial cell fate commitment(GO:0021781) |
| 0.0 |
0.4 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.0 |
0.2 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.0 |
0.0 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.0 |
0.0 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.0 |
0.1 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.0 |
0.1 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 |
0.1 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.0 |
0.1 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.0 |
0.1 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 |
0.2 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.0 |
0.4 |
GO:0060306 |
regulation of membrane repolarization(GO:0060306) |
| 0.0 |
0.0 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.0 |
GO:0033083 |
regulation of immature T cell proliferation(GO:0033083) |
| 0.0 |
0.9 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
0.4 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.0 |
0.1 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.0 |
0.2 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.0 |
0.1 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.0 |
0.0 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.0 |
0.0 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.0 |
0.2 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.0 |
0.1 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.0 |
0.0 |
GO:1904429 |
t-circle formation(GO:0090656) regulation of t-circle formation(GO:1904429) |
| 0.0 |
0.0 |
GO:0019585 |
uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
| 0.0 |
0.1 |
GO:0048548 |
regulation of pinocytosis(GO:0048548) |
| 0.0 |
0.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.1 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.0 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.0 |
0.0 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 |
0.0 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.0 |
0.1 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 |
0.0 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.1 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.2 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.1 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.0 |
0.1 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
0.0 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.0 |
0.0 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.0 |
0.0 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.0 |
0.0 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.1 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 |
0.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
7.1 |
GO:0006412 |
translation(GO:0006412) |
| 0.0 |
0.0 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 |
0.0 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.0 |
0.1 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 0.0 |
0.0 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
0.1 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.0 |
0.2 |
GO:0061037 |
negative regulation of cartilage development(GO:0061037) |
| 0.0 |
0.0 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.0 |
0.0 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 0.0 |
0.1 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.0 |
0.0 |
GO:0090184 |
positive regulation of kidney development(GO:0090184) |
| 0.0 |
0.4 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.0 |
0.1 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.0 |
0.0 |
GO:1900221 |
regulation of beta-amyloid clearance(GO:1900221) |
| 0.0 |
0.1 |
GO:0051180 |
vitamin transport(GO:0051180) |
| 0.0 |
0.0 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.0 |
0.1 |
GO:0042891 |
antibiotic transport(GO:0042891) |
| 0.0 |
0.1 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.0 |
0.1 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.3 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.0 |
0.1 |
GO:0032769 |
negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.0 |
0.3 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.1 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
0.0 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 |
0.1 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.0 |
0.2 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.0 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.0 |
0.2 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.0 |
0.0 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.1 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.0 |
0.1 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.0 |
0.0 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.0 |
0.0 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.0 |
0.0 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.0 |
0.1 |
GO:0036344 |
platelet morphogenesis(GO:0036344) |
| 0.0 |
0.0 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.0 |
0.0 |
GO:0050810 |
regulation of steroid biosynthetic process(GO:0050810) |
| 0.0 |
0.1 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 0.0 |
0.0 |
GO:0009142 |
nucleoside triphosphate biosynthetic process(GO:0009142) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.1 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.1 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.0 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.0 |
0.0 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.0 |
0.0 |
GO:0061013 |
regulation of mRNA catabolic process(GO:0061013) |
| 0.0 |
0.0 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.0 |
0.0 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.0 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.0 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
